#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive familial intrahepatic cholestasis Factor VIII deficiency Myeloproliferative neoplasm Chronic lymphocytic leukaemia Waldenstrom's macroglobulinaemia recurrent Von Willebrand's disease Vitamin B12 deficiency Epilepsy Neuropathy peripheral Frontotemporal dementia Autologous haematopoietic stem cell transplant Fragile X syndrome Cerebellar ataxia Hypertriglyceridaemia Rhabdomyosarcoma recurrent More trials…

    Learn about Rare Diseases

    Mitochondrial myopathy Synovial sarcoma recurrent Hereditary optic atrophy – Life with Disease Turner’s syndrome – Trials in Disease Idiopathic pulmonary fibrosis – Treatment Chronic granulomatous disease – Trials in Disease Hereditary neuropathic amyloidosis – Basic Information Behcet’s syndrome – Treatment Nephrotic syndrome Lennox-Gastaut syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alnuctamab Mometasone Furoate Ph. Eur. Troriluzole Corline Heparin Conjugate AZD5148 Tiemonium Methylsulphate Cetuximab [18F]CPFPX Lactulose Cetrimide Panobinostat Magnesium Sulfate Heptahydrate Ladarixin ARTICAINE HYDROCHLORIDE Reboxetine Rondaptivon Pegol Soya-Bean Oil Refined Doxycycline Lactose Durvalumab More therapies…

    Learn about Your Condition

    Pancreatic neoplasm Oesophageal food impaction Head injury Rectal cancer stage III Breast cancer Back pain Hepatitis alcoholic Brain abscess Uterine cancer Tooth loss Neonatal anoxia Malignant peritoneal neoplasm Spinal cord injury cervical Radicular pain Psychological trauma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. KBC Zagreb

KBC Zagreb

Ulica Mije Kispatica 12, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Acalabrutinib to Standard Treatments for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Acalabrutinib
    Croatia Czechia Hungary Poland

  • Study on the Safety and Effectiveness of Peginterferon Beta-1a for Children and Teens with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Interferon Beta-1A
    • Peginterferon Beta-1A
    Bulgaria Croatia Czechia Hungary Slovakia

  • Study on Diarrhea Discontinuations in Early-stage HER2+ Breast Cancer Patients Treated with Neratinib, Loperamide, and Colesevelam

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Neratinib
    • Loperamide Hydrochloride
    Croatia France Italy Spain

  • Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Vutrisiran
    Austria Belgium Croatia Czechia Denmark France +10

  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Bulgaria Croatia Germany Hungary Italy Lithuania +4

  • Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Lumateperone
    Bulgaria Croatia

  • Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary progressive multiple sclerosis
    Investigated Drugs:
    • Methylprednisolone Sodium Succinate
    • Diphenhydramine Hydrochloride
    • Lidocaine Hydrochloride Monohydrate
    Belgium Bulgaria Croatia France Italy Poland +3

  • Study on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia A with anti factor VIII
    • Haemophilia B with anti factor IX
    Investigated Drugs:
    • Concizumab
    Croatia Denmark France Italy Poland Portugal +2

  • Study on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Pemphigoid
    Investigated Drugs:
    • Efgartigimod Alfa
    • Prednisone
    Bulgaria Croatia Czechia France Germany Greece +8
Previous Page
1 … 9 10 11 12 13 … 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!